Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-024-02649-z, published online 11 March 2024
In this article, the funding section needs be rephrased. Currently it reads:
“This work was supported by the grant PI19/01231 funded by AEI and the European Union. A.R-V contract was funded by the program “CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD (PFIS)”, grant FI20/00213 from the Instituto de Salud Carlos III (ISC-III) and co-funded by the European Union associated with the project PI19/01231.”
It should be updated to:
“This work was supported by the grant PI19/01231 funded by AEI and the European Union. A.R-V contract was funded by the program “CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD (PFIS)”, grant FI20/00213 from the Instituto de Salud Carlos III (ISC-III) and co-funded by the European Union (ERDF/ESF, “A way to make Europe”/“Investing in your future”) associated with the project PI19/01231.
The original article has been updated.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rio-Vilariño, A., Cenigaonandia-Campillo, A., García-Bautista, A. et al. Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. Br J Cancer 130, 1414 (2024). https://doi.org/10.1038/s41416-024-02667-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-024-02667-x
